Click for best price
Biomarkers for Signing Cancer Market Size, Share 2023
This report contains market size and forecasts of Biomarkers for Signing Cancer in Global, including the following market information:
Global Biomarkers for Signing Cancer Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Biomarkers for Signing Cancer market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Genetic Biomarkers Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Biomarkers for Signing Cancer include Bristol-Myers Squibb Company, Sysmex Corporation, QIAGEN, Becton, Dickinson and Company, Agilent Technologies, Abbott Laboratories, Hologic, Quest Diagnostics and Biom?rieux SA, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biomarkers for Signing Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biomarkers for Signing Cancer Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Biomarkers for Signing Cancer Market Segment Percentages, by Type, 2022 (%)
Genetic Biomarkers
Protein Biomarkers
Glyco-biomarkers
Global Biomarkers for Signing Cancer Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Biomarkers for Signing Cancer Market Segment Percentages, by Application, 2022 (%)
Diagnostics
Drug Discovery and Development
Others
Global Biomarkers for Signing Cancer Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Biomarkers for Signing Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biomarkers for Signing Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Biomarkers for Signing Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb Company
Sysmex Corporation
QIAGEN
Becton, Dickinson and Company
Agilent Technologies
Abbott Laboratories
Hologic
Quest Diagnostics
Biom?rieux SA
Illumina
Merck KGaA
Exact Sciences Corporation
F.Hoffmann-La Roche Ltd
Roche Diagnostics
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc
| Report Attributes |
Report Details |
| Report Title |
Biomarkers for Signing Cancer Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
109 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biomarkers for Signing Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biomarkers for Signing Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biomarkers for Signing Cancer Overall Market Size
2.1 Global Biomarkers for Signing Cancer Market Size: 2022 VS 2030
2.2 Global Biomarkers for Signing Cancer Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biomarkers for Signing Cancer Players in Global Market
3.2 Top Global Biomarkers for Signing Cancer Companies Ranked by Revenue
3.3 Global Biomarkers for Signing Cancer Revenue by Companies
3.4 Top 3 and Top 5 Biomarkers for Signing Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Biomarkers for Signing Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biomarkers for Signing Cancer Players in Global Market
3.6.1 List of Global Tier 1 Biomarkers for Signing Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Biomarkers for Signing Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Biomarkers for Signing Cancer Market Size Markets, 2022 & 2030
4.1.2 Genetic Biomarkers
4.1.3 Protein Biomarkers
4.1.4 Glyco-biomarkers
4.2 By Type - Global Biomarkers for Signing Cancer Revenue & Forecasts
4.2.1 By Type - Global Biomarkers for Signing Cancer Revenue, 2018-2023
4.2.2 By Type - Global Biomarkers for Signing Cancer Revenue, 2023-2030
4.2.3 By Type - Global Biomarkers for Signing Cancer Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biomarkers for Signing Cancer Market Size, 2022 & 2030
5.1.2 Diagnostics
5.1.3 Drug Discovery and Development
5.1.4 Others
5.2 By Application - Global Biomarkers for Signing Cancer Revenue & Forecasts
5.2.1 By Application - Global Biomarkers for Signing Cancer Revenue, 2018-2023
5.2.2 By Application - Global Biomarkers for Signing Cancer Revenue, 2023-2030
5.2.3 By Application - Global Biomarkers for Signing Cancer Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Biomarkers for Signing Cancer Market Size, 2022 & 2030
6.2 By Region - Global Biomarkers for Signing Cancer Revenue & Forecasts
6.2.1 By Region - Global Biomarkers for Signing Cancer Revenue, 2018-2023
6.2.2 By Region - Global Biomarkers for Signing Cancer Revenue, 2023-2030
6.2.3 By Region - Global Biomarkers for Signing Cancer Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Biomarkers for Signing Cancer Revenue, 2018-2030
6.3.2 US Biomarkers for Signing Cancer Market Size, 2018-2030
6.3.3 Canada Biomarkers for Signing Cancer Market Size, 2018-2030
6.3.4 Mexico Biomarkers for Signing Cancer Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Biomarkers for Signing Cancer Revenue, 2018-2030
6.4.2 Germany Biomarkers for Signing Cancer Market Size, 2018-2030
6.4.3 France Biomarkers for Signing Cancer Market Size, 2018-2030
6.4.4 U.K. Biomarkers for Signing Cancer Market Size, 2018-2030
6.4.5 Italy Biomarkers for Signing Cancer Market Size, 2018-2030
6.4.6 Russia Biomarkers for Signing Cancer Market Size, 2018-2030
6.4.7 Nordic Countries Biomarkers for Signing Cancer Market Size, 2018-2030
6.4.8 Benelux Biomarkers for Signing Cancer Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Biomarkers for Signing Cancer Revenue, 2018-2030
6.5.2 China Biomarkers for Signing Cancer Market Size, 2018-2030
6.5.3 Japan Biomarkers for Signing Cancer Market Size, 2018-2030
6.5.4 South Korea Biomarkers for Signing Cancer Market Size, 2018-2030
6.5.5 Southeast Asia Biomarkers for Signing Cancer Market Size, 2018-2030
6.5.6 India Biomarkers for Signing Cancer Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Biomarkers for Signing Cancer Revenue, 2018-2030
6.6.2 Brazil Biomarkers for Signing Cancer Market Size, 2018-2030
6.6.3 Argentina Biomarkers for Signing Cancer Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biomarkers for Signing Cancer Revenue, 2018-2030
6.7.2 Turkey Biomarkers for Signing Cancer Market Size, 2018-2030
6.7.3 Israel Biomarkers for Signing Cancer Market Size, 2018-2030
6.7.4 Saudi Arabia Biomarkers for Signing Cancer Market Size, 2018-2030
6.7.5 UAE Biomarkers for Signing Cancer Market Size, 2018-2030
7 Players Profiles
7.1 Bristol-Myers Squibb Company
7.1.1 Bristol-Myers Squibb Company Corporate Summary
7.1.2 Bristol-Myers Squibb Company Business Overview
7.1.3 Bristol-Myers Squibb Company Biomarkers for Signing Cancer Major Product Offerings
7.1.4 Bristol-Myers Squibb Company Biomarkers for Signing Cancer Revenue in Global Market (2018-2023)
7.1.5 Bristol-Myers Squibb Company Key News
7.2 Sysmex Corporation
7.2.1 Sysmex Corporation Corporate Summary
7.2.2 Sysmex Corporation Business Overview
7.2.3 Sysmex Corporation Biomarkers for Signing Cancer Major Product Offerings
7.2.4 Sysmex Corporation Biomarkers for Signing Cancer Revenue in Global Market (2018-2023)
7.2.5 Sysmex Corporation Key News
7.3 QIAGEN
7.3.1 QIAGEN Corporate Summary
7.3.2 QIAGEN Business Overview
7.3.3 QIAGEN Biomarkers for Signing Cancer Major Product Offerings
7.3.4 QIAGEN Biomarkers for Signing Cancer Revenue in Global Market (2018-2023)
7.3.5 QIAGEN Key News
7.4 Becton, Dickinson and Company
7.4.1 Becton, Dickinson and Company Corporate Summary
7.4.2 Becton, Dickinson and Company Business Overview
7.4.3 Becton, Dickinson and Company Biomarkers for Signing Cancer Major Product Offerings
7.4.4 Becton, Dickinson and Company Biomarkers for Signing Cancer Revenue in Global Market (2018-2023)
7.4.5 Becton, Dickinson and Company Key News
7.5 Agilent Technologies
7.5.1 Agilent Technologies Corporate Summary
7.5.2 Agilent Technologies Business Overview
7.5.3 Agilent Technologies Biomarkers for Signing Cancer Major Product Offerings
7.5.4 Agilent Technologies Biomarkers for Signing Cancer Revenue in Global Market (2018-2023)
7.5.5 Agilent Technologies Key News
7.6 Abbott Laboratories
7.6.1 Abbott Laboratories Corporate Summary
7.6.2 Abbott Laboratories Business Overview
7.6.3 Abbott Laboratories Biomarkers for Signing Cancer Major Product Offerings
7.6.4 Abbott Laboratories Biomarkers for Signing Cancer Revenue in Global Market (2018-2023)
7.6.5 Abbott Laboratories Key News
7.7 Hologic
7.7.1 Hologic Corporate Summary
7.7.2 Hologic Business Overview
7.7.3 Hologic Biomarkers for Signing Cancer Major Product Offerings
7.7.4 Hologic Biomarkers for Signing Cancer Revenue in Global Market (2018-2023)
7.7.5 Hologic Key News
7.8 Quest Diagnostics
7.8.1 Quest Diagnostics Corporate Summary
7.8.2 Quest Diagnostics Business Overview
7.8.3 Quest Diagnostics Biomarkers for Signing Cancer Major Product Offerings
7.8.4 Quest Diagnostics Biomarkers for Signing Cancer Revenue in Global Market (2018-2023)
7.8.5 Quest Diagnostics Key News
7.9 Biom?rieux SA
7.9.1 Biom?rieux SA Corporate Summary
7.9.2 Biom?rieux SA Business Overview
7.9.3 Biom?rieux SA Biomarkers for Signing Cancer Major Product Offerings
7.9.4 Biom?rieux SA Biomarkers for Signing Cancer Revenue in Global Market (2018-2023)
7.9.5 Biom?rieux SA Key News
7.10 Illumina
7.10.1 Illumina Corporate Summary
7.10.2 Illumina Business Overview
7.10.3 Illumina Biomarkers for Signing Cancer Major Product Offerings
7.10.4 Illumina Biomarkers for Signing Cancer Revenue in Global Market (2018-2023)
7.10.5 Illumina Key News
7.11 Merck KGaA
7.11.1 Merck KGaA Corporate Summary
7.11.2 Merck KGaA Business Overview
7.11.3 Merck KGaA Biomarkers for Signing Cancer Major Product Offerings
7.11.4 Merck KGaA Biomarkers for Signing Cancer Revenue in Global Market (2018-2023)
7.11.5 Merck KGaA Key News
7.12 Exact Sciences Corporation
7.12.1 Exact Sciences Corporation Corporate Summary
7.12.2 Exact Sciences Corporation Business Overview
7.12.3 Exact Sciences Corporation Biomarkers for Signing Cancer Major Product Offerings
7.12.4 Exact Sciences Corporation Biomarkers for Signing Cancer Revenue in Global Market (2018-2023)
7.12.5 Exact Sciences Corporation Key News
7.13 F.Hoffmann-La Roche Ltd
7.13.1 F.Hoffmann-La Roche Ltd Corporate Summary
7.13.2 F.Hoffmann-La Roche Ltd Business Overview
7.13.3 F.Hoffmann-La Roche Ltd Biomarkers for Signing Cancer Major Product Offerings
7.13.4 F.Hoffmann-La Roche Ltd Biomarkers for Signing Cancer Revenue in Global Market (2018-2023)
7.13.5 F.Hoffmann-La Roche Ltd Key News
7.14 Roche Diagnostics
7.14.1 Roche Diagnostics Corporate Summary
7.14.2 Roche Diagnostics Business Overview
7.14.3 Roche Diagnostics Biomarkers for Signing Cancer Major Product Offerings
7.14.4 Roche Diagnostics Biomarkers for Signing Cancer Revenue in Global Market (2018-2023)
7.14.5 Roche Diagnostics Key News
7.15 Thermo Fisher Scientific, Inc.
7.15.1 Thermo Fisher Scientific, Inc. Corporate Summary
7.15.2 Thermo Fisher Scientific, Inc. Business Overview
7.15.3 Thermo Fisher Scientific, Inc. Biomarkers for Signing Cancer Major Product Offerings
7.15.4 Thermo Fisher Scientific, Inc. Biomarkers for Signing Cancer Revenue in Global Market (2018-2023)
7.15.5 Thermo Fisher Scientific, Inc. Key News
7.16 Bio-Rad Laboratories, Inc
7.16.1 Bio-Rad Laboratories, Inc Corporate Summary
7.16.2 Bio-Rad Laboratories, Inc Business Overview
7.16.3 Bio-Rad Laboratories, Inc Biomarkers for Signing Cancer Major Product Offerings
7.16.4 Bio-Rad Laboratories, Inc Biomarkers for Signing Cancer Revenue in Global Market (2018-2023)
7.16.5 Bio-Rad Laboratories, Inc Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Biomarkers for Signing Cancer Market Opportunities & Trends in Global Market
Table 2. Biomarkers for Signing Cancer Market Drivers in Global Market
Table 3. Biomarkers for Signing Cancer Market Restraints in Global Market
Table 4. Key Players of Biomarkers for Signing Cancer in Global Market
Table 5. Top Biomarkers for Signing Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Biomarkers for Signing Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Biomarkers for Signing Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Biomarkers for Signing Cancer Product Type
Table 9. List of Global Tier 1 Biomarkers for Signing Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biomarkers for Signing Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Biomarkers for Signing Cancer Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Biomarkers for Signing Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Biomarkers for Signing Cancer Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Biomarkers for Signing Cancer Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Biomarkers for Signing Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Biomarkers for Signing Cancer Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Biomarkers for Signing Cancer Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Biomarkers for Signing Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Biomarkers for Signing Cancer Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Biomarkers for Signing Cancer Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Biomarkers for Signing Cancer Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Biomarkers for Signing Cancer Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Biomarkers for Signing Cancer Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Biomarkers for Signing Cancer Revenue, (US$, Mn), 2023-2030
Table 30. Bristol-Myers Squibb Company Corporate Summary
Table 31. Bristol-Myers Squibb Company Biomarkers for Signing Cancer Product Offerings
Table 32. Bristol-Myers Squibb Company Biomarkers for Signing Cancer Revenue (US$, Mn), (2018-2023)
Table 33. Sysmex Corporation Corporate Summary
Table 34. Sysmex Corporation Biomarkers for Signing Cancer Product Offerings
Table 35. Sysmex Corporation Biomarkers for Signing Cancer Revenue (US$, Mn), (2018-2023)
Table 36. QIAGEN Corporate Summary
Table 37. QIAGEN Biomarkers for Signing Cancer Product Offerings
Table 38. QIAGEN Biomarkers for Signing Cancer Revenue (US$, Mn), (2018-2023)
Table 39. Becton, Dickinson and Company Corporate Summary
Table 40. Becton, Dickinson and Company Biomarkers for Signing Cancer Product Offerings
Table 41. Becton, Dickinson and Company Biomarkers for Signing Cancer Revenue (US$, Mn), (2018-2023)
Table 42. Agilent Technologies Corporate Summary
Table 43. Agilent Technologies Biomarkers for Signing Cancer Product Offerings
Table 44. Agilent Technologies Biomarkers for Signing Cancer Revenue (US$, Mn), (2018-2023)
Table 45. Abbott Laboratories Corporate Summary
Table 46. Abbott Laboratories Biomarkers for Signing Cancer Product Offerings
Table 47. Abbott Laboratories Biomarkers for Signing Cancer Revenue (US$, Mn), (2018-2023)
Table 48. Hologic Corporate Summary
Table 49. Hologic Biomarkers for Signing Cancer Product Offerings
Table 50. Hologic Biomarkers for Signing Cancer Revenue (US$, Mn), (2018-2023)
Table 51. Quest Diagnostics Corporate Summary
Table 52. Quest Diagnostics Biomarkers for Signing Cancer Product Offerings
Table 53. Quest Diagnostics Biomarkers for Signing Cancer Revenue (US$, Mn), (2018-2023)
Table 54. Biom?rieux SA Corporate Summary
Table 55. Biom?rieux SA Biomarkers for Signing Cancer Product Offerings
Table 56. Biom?rieux SA Biomarkers for Signing Cancer Revenue (US$, Mn), (2018-2023)
Table 57. Illumina Corporate Summary
Table 58. Illumina Biomarkers for Signing Cancer Product Offerings
Table 59. Illumina Biomarkers for Signing Cancer Revenue (US$, Mn), (2018-2023)
Table 60. Merck KGaA Corporate Summary
Table 61. Merck KGaA Biomarkers for Signing Cancer Product Offerings
Table 62. Merck KGaA Biomarkers for Signing Cancer Revenue (US$, Mn), (2018-2023)
Table 63. Exact Sciences Corporation Corporate Summary
Table 64. Exact Sciences Corporation Biomarkers for Signing Cancer Product Offerings
Table 65. Exact Sciences Corporation Biomarkers for Signing Cancer Revenue (US$, Mn), (2018-2023)
Table 66. F.Hoffmann-La Roche Ltd Corporate Summary
Table 67. F.Hoffmann-La Roche Ltd Biomarkers for Signing Cancer Product Offerings
Table 68. F.Hoffmann-La Roche Ltd Biomarkers for Signing Cancer Revenue (US$, Mn), (2018-2023)
Table 69. Roche Diagnostics Corporate Summary
Table 70. Roche Diagnostics Biomarkers for Signing Cancer Product Offerings
Table 71. Roche Diagnostics Biomarkers for Signing Cancer Revenue (US$, Mn), (2018-2023)
Table 72. Thermo Fisher Scientific, Inc. Corporate Summary
Table 73. Thermo Fisher Scientific, Inc. Biomarkers for Signing Cancer Product Offerings
Table 74. Thermo Fisher Scientific, Inc. Biomarkers for Signing Cancer Revenue (US$, Mn), (2018-2023)
Table 75. Bio-Rad Laboratories, Inc Corporate Summary
Table 76. Bio-Rad Laboratories, Inc Biomarkers for Signing Cancer Product Offerings
Table 77. Bio-Rad Laboratories, Inc Biomarkers for Signing Cancer Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Biomarkers for Signing Cancer Segment by Type in 2022
Figure 2. Biomarkers for Signing Cancer Segment by Application in 2022
Figure 3. Global Biomarkers for Signing Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biomarkers for Signing Cancer Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Biomarkers for Signing Cancer Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biomarkers for Signing Cancer Revenue in 2022
Figure 8. By Type - Global Biomarkers for Signing Cancer Revenue Market Share, 2018-2030
Figure 9. By Application - Global Biomarkers for Signing Cancer Revenue Market Share, 2018-2030
Figure 10. By Region - Global Biomarkers for Signing Cancer Revenue Market Share, 2018-2030
Figure 11. By Country - North America Biomarkers for Signing Cancer Revenue Market Share, 2018-2030
Figure 12. US Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Biomarkers for Signing Cancer Revenue Market Share, 2018-2030
Figure 16. Germany Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 17. France Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Biomarkers for Signing Cancer Revenue Market Share, 2018-2030
Figure 24. China Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 28. India Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Biomarkers for Signing Cancer Revenue Market Share, 2018-2030
Figure 30. Brazil Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Biomarkers for Signing Cancer Revenue Market Share, 2018-2030
Figure 33. Turkey Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Biomarkers for Signing Cancer Revenue, (US$, Mn), 2018-2030
Figure 37. Bristol-Myers Squibb Company Biomarkers for Signing Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Sysmex Corporation Biomarkers for Signing Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. QIAGEN Biomarkers for Signing Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Becton, Dickinson and Company Biomarkers for Signing Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Agilent Technologies Biomarkers for Signing Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Laboratories Biomarkers for Signing Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Hologic Biomarkers for Signing Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Quest Diagnostics Biomarkers for Signing Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Biom?rieux SA Biomarkers for Signing Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Illumina Biomarkers for Signing Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Merck KGaA Biomarkers for Signing Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Exact Sciences Corporation Biomarkers for Signing Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. F.Hoffmann-La Roche Ltd Biomarkers for Signing Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Roche Diagnostics Biomarkers for Signing Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Thermo Fisher Scientific, Inc. Biomarkers for Signing Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Bio-Rad Laboratories, Inc Biomarkers for Signing Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
